The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patterns of disease, treatment, and outcomes of esophageal cancer arising within a previous radiation treatment field.
 
Lucy Xiaolu Ma
No Relationships to Disclose
 
Peiran Sun
No Relationships to Disclose
 
Osvaldo Espin-Garcia
No Relationships to Disclose
 
Chihiro Suzuki
No Relationships to Disclose
 
Di Maria Jiang
No Relationships to Disclose
 
Charles Henry Lim
Honoraria - Ipsen; Ipsen; Ipsen; Ipsen
 
Kirsty Taylor
No Relationships to Disclose
 
Bryan Anthony Chan
Honoraria - Roche; Roche; Roche; Roche
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Ipsen; Ipsen; Ipsen; Ipsen
 
Hao-Wen Sim
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst)
 
Akina Natori
No Relationships to Disclose
 
Eric Xueyu Chen
No Relationships to Disclose
 
Geoffrey Liu
Honoraria - Abbvie; Abbvie; Abbvie; Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck; Merck; Merck; Merck; novartis; novartis; novartis; novartis; pfizer; pfizer; pfizer; pfizer; Roche Canada; Roche Canada; Roche Canada; Roche Canada; Takeda; Takeda; Takeda; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; novartis; novartis; novartis; novartis; pfizer; pfizer; pfizer; pfizer; Roche Canada; Roche Canada; Roche Canada; Roche Canada; takeda; takeda; takeda; takeda
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
Research Funding - roche (Inst); roche (Inst); roche (Inst); roche (Inst)
 
Jennifer J. Knox
Honoraria - Novartis; Novartis; Novartis; Novartis
Consulting or Advisory Role - Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck; Merck; Merck; Merck
 
Jonathan Yeung
No Relationships to Disclose
 
Gail Elizabeth Darling
No Relationships to Disclose
 
John Kim
No Relationships to Disclose
 
Sangeetha Kalimuthu
No Relationships to Disclose
 
Elena Elimova
Employment - Merck (I); Merck (I); Merck (I); Merck (I)
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst)
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
 
Raymond Woo-Jun Jang
Consulting or Advisory Role - Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst)